Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

A Call to Make the Human Dimension of Science a Core Component of Scientific Journals.

Bolli R.

Circ Res. 2018 Mar 30;122(7):907-910. doi: 10.1161/CIRCRESAHA.118.312947. No abstract available.

PMID:
29599270
2.

Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2018 Mar 6;8(1):4257. doi: 10.1038/s41598-018-22121-2.

3.

Recognizing the Top Reviewers of 2017 for Circulation Research.

Bolli R.

Circ Res. 2018 Feb 16;122(4):551. doi: 10.1161/CIRCRESAHA.118.312743. No abstract available.

PMID:
29449362
4.

Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose.

Tang XL, Nakamura S, Li Q, Wysoczynski M, Gumpert AM, Wu WJ, Hunt G, Stowers H, Ou Q, Bolli R.

J Am Heart Assoc. 2018 Feb 13;7(4). pii: e007400. doi: 10.1161/JAHA.117.007400.

5.

Circulation Research 2017 Best Manuscript Award Winners.

Bolli R.

Circ Res. 2018 Feb 2;122(3):396-398. doi: 10.1161/CIRCRESAHA.118.312681. No abstract available.

PMID:
29420207
6.

Guidelines for experimental models of myocardial ischemia and infarction.

Lindsey ML, Bolli R, Canty JM Jr., Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G.

Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H812-H838. doi: 10.1152/ajpheart.00335.2017. Epub 2018 Jan 12.

7.

Translational Research in Cardiovascular Repair: A Call for a Paradigm Shift.

Chamuleau SAJ, van der Naald M, Climent AM, Kraaijeveld AO, Wever KE, Duncker DJ, Fernández-Avilés F, Bolli R; Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Group.

Circ Res. 2018 Jan 19;122(2):310-318. doi: 10.1161/CIRCRESAHA.117.311565. Review.

PMID:
29348252
8.

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group.

Circ Res. 2018 Jan 19;122(2):199-201. doi: 10.1161/CIRCRESAHA.117.312099. No abstract available.

PMID:
29348246
9.

Cell therapy for heart disease: current status and future directions.

Kahlon A, Vaidya G, Bolli R.

Minerva Cardioangiol. 2018 Jan 10. doi: 10.23736/S0026-4725.18.04596-6. [Epub ahead of print]

PMID:
29327894
10.

Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.

Uchida S, Bolli R.

Antioxid Redox Signal. 2017 Sep 28. doi: 10.1089/ars.2017.7262. [Epub ahead of print]

PMID:
28847161
11.

New Initiatives to Improve the Rigor and Reproducibility of Articles Published in Circulation Research.

Bolli R.

Circ Res. 2017 Aug 18;121(5):472-479. doi: 10.1161/CIRCRESAHA.117.311678. No abstract available.

PMID:
28819032
12.

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.

Yanamandala M, Zhu W, Garry DJ, Kamp TJ, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu SD, Dorn GW 2nd, Bolli R, Kitsis RN, Zhang J.

J Am Coll Cardiol. 2017 Aug 8;70(6):766-775. doi: 10.1016/j.jacc.2017.06.012. Review.

13.

The Impact Factor of Circulation Research Reaches a New High.

Bolli R.

Circ Res. 2017 Jul 21;121(3):199. doi: 10.1161/CIRCRESAHA.117.311564. No abstract available.

PMID:
28729447
14.

Cardiomyocyte Regeneration: A Consensus Statement.

Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisén J, Giacca M, Hare JM, Houser S, Lee RT, Marbán E, Martin JF, Molkentin JD, Murry CE, Riley PR, Ruiz-Lozano P, Sadek HA, Sussman MA, Hill JA.

Circulation. 2017 Aug 15;136(7):680-686. doi: 10.1161/CIRCULATIONAHA.117.029343. Epub 2017 Jul 6. Review. No abstract available.

PMID:
28684531
15.

Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion.

Moore JB 4th, Zhao J, Fischer AG, Keith MCL, Hagan D, Wysoczynski M, Bolli R.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e006183. doi: 10.1161/JAHA.117.006183.

16.

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.

Jokerst JV, Cauwenberghs N, Kuznetsova T, Haddad F, Sweeney T, Hou J, Rosenberg-Hasson Y, Zhao E, Schutt R, Bolli R, Traverse JH, Pepine CJ, Henry TD, Schulman IH, Moyé L, Taylor DA, Yang PC.

Sci Rep. 2017 Jun 30;7(1):4419. doi: 10.1038/s41598-017-04801-7. Erratum in: Sci Rep. 2018 Mar 6;8(1):4257.

17.

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.

Youssef AA, Ross EG, Bolli R, Pepine CJ, Leeper NJ, Yang PC.

JACC Basic Transl Sci. 2016 Oct;1(6):510-523. doi: 10.1016/j.jacbts.2016.06.010.

18.

Global position paper on cardiovascular regenerative medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee.

Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248. No abstract available.

19.

Neurocognitive Risk With PCSK9 Inhibitors: Need for More Robust Evidence.

Khan AR, Riaz H, Farid T, Bolli R.

J Am Coll Cardiol. 2017 May 16;69(19):2468-2469. doi: 10.1016/j.jacc.2017.02.063. No abstract available.

PMID:
28494987
20.

Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.

Shahrivari M, Wise E, Resende M, Shuster JJ, Zhang J, Bolli R, Cooke JP, Hare JM, Henry TD, Khan A, Taylor DA, Traverse JH, Yang PC, Pepine CJ, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2017 Jun 9;120(12):1947-1957. doi: 10.1161/CIRCRESAHA.116.309947. Epub 2017 May 10.

PMID:
28490433
21.

Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence.

Wysoczynski M, Guo Y, Moore JB 4th, Muthusamy S, Li Q, Nasr M, Li H, Nong Y, Wu W, Tomlin AA, Zhu X, Hunt G, Gumpert AM, Book MJ, Khan A, Tang XL, Bolli R.

J Am Coll Cardiol. 2017 Apr 11;69(14):1824-1838. doi: 10.1016/j.jacc.2017.01.048.

22.

Stem cells: Cell therapy for cardiac repair: what is needed to move forward?

Bolli R, Ghafghazi S.

Nat Rev Cardiol. 2017 May;14(5):257-258. doi: 10.1038/nrcardio.2017.38. Epub 2017 Mar 31. No abstract available.

PMID:
28361979
23.

Trainees in the Spotlight: Yet Another Addition to Our Portfolio.

Bolli R.

Circ Res. 2017 Mar 31;120(7):1048-1049. doi: 10.1161/CIRCRESAHA.117.310936. No abstract available.

24.

Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells.

Al-Maqtari T, Hong KU, Vajravelu BN, Moktar A, Cao P, Moore JB 4th, Bolli R.

PLoS One. 2017 Mar 29;12(3):e0174242. doi: 10.1371/journal.pone.0174242. eCollection 2017.

25.

The 10 Most Read Articles Published in Circulation Research in 2016.

Bolli R; Editors.

Circ Res. 2017 Mar 3;120(5):767-771. doi: 10.1161/CIRCRESAHA.117.310755. No abstract available.

26.

Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.

Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert AM, Nasr M, Muthusamy S, Li H, Book M, Khan A, Hong KU, Li Q, Bolli R.

Basic Res Cardiol. 2017 Mar;112(2):18. doi: 10.1007/s00395-017-0606-5. Epub 2017 Feb 16.

27.

Announcing the "Meet the First Author" Page.

Bolli R.

Circ Res. 2017 Feb 17;120(4):595. doi: 10.1161/CIRCRESAHA.117.310704. No abstract available.

28.

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT; Cardiovascular Cell Therapy Research Network (CCTRN).

Circulation. 2017 Apr 11;135(15):1417-1428. doi: 10.1161/CIRCULATIONAHA.116.025707. Epub 2017 Feb 16.

29.

Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come.

Bolli R.

Circ Res. 2017 Mar 31;120(7):1072-1074. doi: 10.1161/CIRCRESAHA.117.310710. Epub 2017 Feb 8. No abstract available.

30.

Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors.

Khan AR, Bavishi C, Riaz H, Farid TA, Khan S, Atlas M, Hirsch G, Ikram S, Bolli R.

Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e003153. doi: 10.1161/CIRCOUTCOMES.116.003153.

31.

Introducing Yet Another Addition to Our Portfolio: Promising Young Investigators.

Bolli R.

Circ Res. 2016 Nov 11;119(11):1161. doi: 10.1161/CIRCRESAHA.116.310158. No abstract available.

32.

Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.

Contreras A, Orozco AF, Resende M, Schutt RC, Traverse JH, Henry TD, Lai D, Cooke JP, Bolli R, Cohen ML, Moyé L, Pepine CJ, Yang PC, Perin EC, Willerson JT, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Basic Res Cardiol. 2017 Jan;112(1):3. Epub 2016 Nov 23.

33.

Oxygen Administration Does Not Influence the Prognosis of Acute Myocardial Infarction: A Meta-Analysis.

Khan AR, Abdulhak AB, Luni FK, Farid TA, Riaz H, Ruzieh M, Pham L, Hirsch G, Bolli R.

Am J Ther. 2016 Nov 2. [Epub ahead of print]

PMID:
27846023
34.

TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate.

Hamid T, Xu Y, Ismahil MA, Li Q, Jones SP, Bhatnagar A, Bolli R, Prabhu SD.

Am J Physiol Heart Circ Physiol. 2016 Nov 1;311(5):H1189-H1201. doi: 10.1152/ajpheart.00904.2015. Epub 2016 Sep 2.

35.

Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.

Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2016 Sep;179:142-50. doi: 10.1016/j.ahj.2016.06.018. Epub 2016 Jul 6.

36.

Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.

Cattepoel S, Gaida A, Kropf A, Nolte MW, Bolli R, Miescher SM.

PLoS One. 2016 Aug 25;11(8):e0161826. doi: 10.1371/journal.pone.0161826. eCollection 2016.

37.

A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells.

Wysoczynski M, Dassanayaka S, Zafir A, Ghafghazi S, Long BW, Noble C, DeMartino AM, Brittian KR, Bolli R, Jones SP.

Front Cell Dev Biol. 2016 Aug 3;4:78. doi: 10.3389/fcell.2016.00078. eCollection 2016.

38.

The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.

Moore JB 4th, Zhao J, Keith MC, Amraotkar AR, Wysoczynski M, Hong KU, Bolli R.

Stem Cells. 2016 Dec;34(12):2916-2929. doi: 10.1002/stem.2471. Epub 2016 Sep 1.

39.

Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy.

Tokita Y, Tang XL, Li Q, Wysoczynski M, Hong KU, Nakamura S, Wu WJ, Xie W, Li D, Hunt G, Ou Q, Stowers H, Bolli R.

Circ Res. 2016 Aug 19;119(5):635-51. doi: 10.1161/CIRCRESAHA.116.308937. Epub 2016 Jun 30.

40.

Recognizing the Top Reviewers for Circulation Research.

Bolli R.

Circ Res. 2016 Jun 10;118(12):1866. doi: 10.1161/CIRCRESAHA.116.309084. No abstract available.

41.

STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus.

Ding C, Chen X, Dascani P, Hu X, Bolli R, Zhang HG, Mcleish KR, Yan J.

J Immunol. 2016 Jun 1;196(11):4477-86. doi: 10.4049/jimmunol.1502043. Epub 2016 Apr 25.

42.

Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Salabei JK, Lorkiewicz PK, Mehra P, Gibb AA, Haberzettl P, Hong KU, Wei X, Zhang X, Li Q, Wysoczynski M, Bolli R, Bhatnagar A, Hill BG.

J Biol Chem. 2016 Jun 24;291(26):13634-48. doi: 10.1074/jbc.M116.722496. Epub 2016 May 5.

43.

Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.

Khan AR, Farid TA, Pathan A, Tripathi A, Ghafghazi S, Wysoczynski M, Bolli R.

Circ Res. 2016 Mar 18;118(6):984-93. doi: 10.1161/CIRCRESAHA.115.308056. Epub 2016 Jan 13. Review.

44.
45.

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.

Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, Wu JC, Bolli R, Perin EC, Moyé L, Simari RD, Wolf A, Hare JM; Cardiovascular Cell Therapy Research Network.

Stem Cells Transl Med. 2016 Feb;5(2):186-91. doi: 10.5966/sctm.2015-0101. Epub 2015 Dec 18. Review.

46.

Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.

Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moyé L, Ebert RF, Bolli R, Simari RD, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Cell Transplant. 2016;25(9):1675-1687. Epub 2015 Nov 19.

47.

O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.

Zafir A, Bradley JA, Long BW, Muthusamy S, Li Q, Hill BG, Wysoczynski M, Prabhu SD, Bhatnagar A, Bolli R, Jones SP.

PLoS One. 2015 Nov 13;10(11):e0142939. doi: 10.1371/journal.pone.0142939. eCollection 2015.

48.

Cell Therapy Needs Rigorous Translational Studies in Large Animal Models.

Bolli R, Ghafghazi S.

J Am Coll Cardiol. 2015 Nov 3;66(18):2000-2004. doi: 10.1016/j.jacc.2015.09.002. No abstract available.

49.

C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways.

Vajravelu BN, Hong KU, Al-Maqtari T, Cao P, Keith MC, Wysoczynski M, Zhao J, Moore JB 4th, Bolli R.

PLoS One. 2015 Oct 16;10(10):e0140798. doi: 10.1371/journal.pone.0140798. eCollection 2015.

50.

Editor's Preamble to the Profile of James Willerson.

Bolli R.

Circ Res. 2015 Oct 9;117(9):e73-4. doi: 10.1161/CIRCRESAHA.115.307570. No abstract available.

Supplemental Content

Support Center